Theravance Bio reports 3Q loss

GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Tuesday reported a loss of $66.9 million in its third quarter.

On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of $1.27.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.22 per share.

The biopharmaceutical company posted revenue of $4.3 million in the period.

Theravance Bio shares have decreased 12 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $28.19, an increase of 9 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH